JPWO2020210697A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020210697A5 JPWO2020210697A5 JP2021559986A JP2021559986A JPWO2020210697A5 JP WO2020210697 A5 JPWO2020210697 A5 JP WO2020210697A5 JP 2021559986 A JP2021559986 A JP 2021559986A JP 2021559986 A JP2021559986 A JP 2021559986A JP WO2020210697 A5 JPWO2020210697 A5 JP WO2020210697A5
- Authority
- JP
- Japan
- Prior art keywords
- biotin
- insulin
- glycero
- composition
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962833228P | 2019-04-12 | 2019-04-12 | |
| US62/833,228 | 2019-04-12 | ||
| US202062988748P | 2020-03-12 | 2020-03-12 | |
| US62/988,748 | 2020-03-12 | ||
| PCT/US2020/027762 WO2020210697A1 (en) | 2019-04-12 | 2020-04-10 | Lipid-based nanoparticles and use of same in optimized insulin dosing regimens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022526842A JP2022526842A (ja) | 2022-05-26 |
| JPWO2020210697A5 true JPWO2020210697A5 (enExample) | 2023-04-17 |
Family
ID=72748579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559986A Pending JP2022526842A (ja) | 2019-04-12 | 2020-04-10 | 脂質ベースのナノ粒子および最適化されたインスリン投薬レジメンにおけるその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10918700B2 (enExample) |
| EP (1) | EP3952904A4 (enExample) |
| JP (1) | JP2022526842A (enExample) |
| AU (1) | AU2020271901A1 (enExample) |
| CA (1) | CA3136665A1 (enExample) |
| WO (1) | WO2020210697A1 (enExample) |
| ZA (1) | ZA202108217B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8962015B2 (en) | 2007-09-28 | 2015-02-24 | Sdg, Inc. | Orally bioavailable lipid-based constructs |
| US20210137838A1 (en) * | 2017-03-13 | 2021-05-13 | Sdg, Inc. | Lipid-based nanoparticles with enhanced stability |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4863896A (en) * | 1984-05-03 | 1989-09-05 | Technology Unlimited, Inc. | Diabetic control by combined insulin forms |
| WO1999059545A1 (en) * | 1998-05-19 | 1999-11-25 | Sdg, Inc. | Targeted liposomal drug delivery system |
| CN1325126C (zh) * | 2001-11-16 | 2007-07-11 | 梅德创新股份公司 | 医药用的泵装置 |
| EP1858545A2 (en) * | 2005-03-04 | 2007-11-28 | Curedm Inc. | Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions |
| US20110135725A1 (en) * | 2005-05-23 | 2011-06-09 | Sdg, Inc. | Lipid Construct for Delivery of Insulin to a Mammal |
| ZA200710055B (en) * | 2005-05-23 | 2009-03-25 | Sdg Inc | Lipid construct for delivery of insulin to a mammal |
| TWI532497B (zh) | 2008-08-11 | 2016-05-11 | 曼凱公司 | 超快起作用胰島素之用途 |
| US20120035105A1 (en) | 2009-01-09 | 2012-02-09 | Sdg, Inc. | Insulin Therapies for the Treatment of Diabetes, Diabetes Related Ailments, and/or Diseases or Conditions Other Than Diabetes or Diabetes Related Ailments |
| EP2727587A1 (en) * | 2012-10-30 | 2014-05-07 | Pharnext | Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level |
| US20210137838A1 (en) * | 2017-03-13 | 2021-05-13 | Sdg, Inc. | Lipid-based nanoparticles with enhanced stability |
| EP3483629B1 (en) * | 2017-11-09 | 2021-12-29 | Veoneer Sweden AB | Detecting a parking row with a vehicle radar system |
| AU2019205795A1 (en) | 2018-01-05 | 2020-07-09 | Sdg, Inc. | Compositions comprising lipid-based nanoparticles for treating diabetes mellitus |
-
2020
- 2020-04-10 AU AU2020271901A patent/AU2020271901A1/en not_active Abandoned
- 2020-04-10 JP JP2021559986A patent/JP2022526842A/ja active Pending
- 2020-04-10 EP EP20788205.1A patent/EP3952904A4/en active Pending
- 2020-04-10 CA CA3136665A patent/CA3136665A1/en active Pending
- 2020-04-10 WO PCT/US2020/027762 patent/WO2020210697A1/en not_active Ceased
- 2020-04-10 US US16/846,101 patent/US10918700B2/en active Active
-
2021
- 2021-01-19 US US17/151,980 patent/US20210379160A1/en not_active Abandoned
- 2021-10-25 ZA ZA2021/08217A patent/ZA202108217B/en unknown
-
2023
- 2023-05-22 US US18/321,429 patent/US20240139288A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023120371A5 (enExample) | ||
| JP2025085727A5 (enExample) | ||
| US20220160841A1 (en) | Glucose-responsive insulin delivery microneedle system | |
| JP7656353B2 (ja) | 向上した安定性を有する脂質ベースのナノ粒子 | |
| JP2020510705A5 (enExample) | ||
| CN105688191A (zh) | 促胰岛素释放肽的混悬制剂及其应用 | |
| CA3055421A1 (en) | Oral delivery of physiologically active substances | |
| CN111629746B (zh) | 具有超快响应的用于葡萄糖触发胰岛素递送的电荷可切换聚合物储库 | |
| JP7517691B2 (ja) | 糖尿病を処置するための脂質ベースのナノ粒子を含む組成物 | |
| US20240139288A1 (en) | Lipid-based nanoparticles and use of same in optimized insulin dosing regimens | |
| KR20210049864A (ko) | 폐루프 인슐린 전달을 위한 포도당 반응성 매트릭스를 갖는 마이크로니들 배열 패치 | |
| CN116867509A (zh) | 用于葡萄糖响应性胰岛素递送的可注射可生物降解的聚合物复合物 | |
| JPWO2020210697A5 (enExample) | ||
| JPWO2019136386A5 (enExample) | ||
| HK1245105B (en) | Glucose-responsive insulin delivery system using hypoxia-sensitive nanocomposites |